LOS ANGELES, CA / ACCESSWIRE / April 29, 2020 / Compare-autoinsurance.org has launched a new blog post that presents how car insurance companies can help drivers during this coronavirus pandemic.

For more info and free car insurance quotes, visit https://compare-autoinsurance.org/car-insurance-companies-help-drivers-pass-through-these-times-of-financial-hardship-caused-by-the-coronavirus-pandemic/

Drives who have been financially affected by the current COVID-19 outbreak can ask for help from their car insurance companies. Some car insurance providers are offering payment flexibility, they are suspending policy cancellations due to nonpayment, or they are automatically renewing policies even if the drivers can't pay.

During these difficult times for everyone, car insurance companies understand their customers. Drivers who have financial difficulties caused by the coronavirus pandemic, should contact their car insurance providers and check all the helping options that are available to them.

Compare-autoinsurance.org (https://compare-autoinsurance.org/) presents a list of options that car insurance providers present to their customers that are experiencing financial troubles:

Car insurance providers are offering coronavirus-related payment delays. Many car insurance providers are willing to work with their customers who are financially affected by the COVDI-19 outbreak. Car insurance companies like Allstate, Geico, MetLife, or Progressive are offering assistance in different forms. In general, they offer the possibility to pause cancellation of premiums due to nonpayment,
Insurance companies can suspend car coverage. Suspending coverage pauses the policy but doesn't cancels it. During the period of suspension, drivers will not have a coverage lapse. Also, drivers may need to file an "affidavit of non-use" from their state's department of motor vehicles to halt state-required auto coverage. This document lets the state know that the drivers won't use their cars for a given period. Most insurers, including Allstate, CNA, Farmers, Geico, Progressive, and Travelers are pausing policy cancelations of their customers who are having financial difficulties during the coronavirus outbreak.
Insurance providers are offering flexible payments and special payment plans. During these difficult times, car insurance companies are doing all they can to help their customers. Drivers may choose to pay less than their usual amount bill, and the unpaid bill will be evenly distributed among the remaining payments. No matter who provides the car insurance, drivers who are affected by this pandemic should contact their insurers immediately to discuss a custom payment plan.
Insures allow drivers to reduce their coverage. Another option to explore is the reduction of car coverage. Car insurance companies allow drivers to reduce their coverage during this pandemic. While the car is out of use, drivers shouldn't pay for unneeded coverage. Drivers should reduce their car coverage to the coverage required by the state law. However, drivers should consider keeping or adding comprehensive coverage that will cover their vehicles for different problems not related to driving like fire, flooding, animal damage, vandalism, and theft.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"During these difficult times, when everyone is struggling, drivers are not left alone. Car insurance companies are offering a helping hand to those drivers who have troubles paying their insurance bills", said Russell Rabichev, Marketing Director of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 587553

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Tilary securities between January 15, 2019 and March 2, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/tlry.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the purported advantages of the ABG Agreement were significantly overstated; (2) the underperformance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

On March 2, 2020, Tilray announced its financial results for the fourth quarter and full year 2019, which fell significantly short of consensus estimates and included a net loss of $219.1 million for the quarter, a $112 million impairment charge related to assets, and a $68 million inventory write-down. On this news, Tilray's stock price fell $2.33 per share, or 15.18%, to close at $13.02 per share on March 3, 2020.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/tlry or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Tilary you have until May 5, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 587028

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Fifth Third Bancorp ("Fifth Third" or "the Company") (NASDAQ:FITB) on behalf of shareholders who purchased Fifth Third securities between February 26, 2016, and March 6, 2020, inclusive (the ''Class Period''). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/fitb.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, defendants made false and misleading and/or failed to disclose that: (1) as a result of Fifth Third Bank's aggressive incentive policies to promote its cross-sell strategy, Fifth Third Bank employees engaged in unauthorized conduct with customer accounts; (2) since at least 2008, Fifth Third Bank, and by extension, Fifth Third, was aware of such unauthorized conduct and, thus, that it was violating relevant regulations and laws aimed at protecting its consumers; (3) Fifth Third failed to properly implement and monitor its cross-sell program, detect and stop misconduct, and identify and remediate harmed consumers; (4) all the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny or investigation; (5) Fifth Third's revenues were in part the product of unlawful conduct and thus unsustainable; and (6) as a result, the Company's public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/fitb or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Fifth Third you have until June 8, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 587055

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against PharmaCielo Ltd. ("PharmaCielo" or "the Company") (OTCQX:PCLOF) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired PharmaCielo securities between June 21, 2019 and March 2, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/pclof.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC; (2) PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp.; (3) PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed; (4) the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants; (5) PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and (6) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/pclof or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in PharmaCielo you have until May 5, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 587025

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Groupon, Inc. ("Groupon" or the "Company") (NASDAQ:GRPN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Groupon securities between November 4, 2019 and February 18, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/grpn.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/grpn or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Groupon you have until June 29, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: 

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 587591

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Canaan Inc. ("Canaan" or the Company") (NASDAQ:CAN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Canaan securities pursuant and/or traceable to the Company's initial public offering commenced on or about November 20, 2019. Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/can.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the purported "strategic cooperation" was actually a transaction with a related party; (2) the company's financial health was worse than what was actually reported; (3) the company had recently removed numerous distributors from its website just prior to the IPO, many of which were small or suspicious businesses; and (4) several of the Company's largest Chinese clients in prior years were clients who were not in the Bitcoin mining industry and, thus, would likely not be repeat customers.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/can or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Canaan you have until May 4, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 587021

VANCOUVER, BC / ACCESSWIRE / April 29, 2020 / A2Z Technologies Canada Corp. ("A2Z" or the "Company") (TSXV:AZ) (FSE:A23), a pioneer in military robotics, services, and innovation in the auto industry, today released an investor update regarding the phased rollout of the Fuel Tank Intelligent Containment System (FTICS) capsule, the Company's innovative product for the automobile industry, and other business updates.

Fuel Tank Intelligent Containment System (FTICS) capsule project

"Despite the COVID-19 pandemic, the FTICS project is continuing as scheduled. The rollout will take place over the next several months, and we have received input and feedback from a prospective client that is tremendously helpful." Mr. Joseph, the Company's CEO stated, and continued, "The FTICS capsule market potential is significantly larger than our initial assumptions, and we look forward to providing further updates in the weeks ahead."

Timing of Reporting of 2019 Financial Results Due to Delays Caused by COVID-19

The Company wishes to update on timing of the release and filing of its financial results for the year ended December 31, 2019.

In response to the ongoing global COVID-19 pandemic, the Canadian Securities Administrators have recently announced temporary blanket relief allowing market participants an additional 45 days in which to complete certain regulatory filings required to be made on or before June 1, 2020 (including financial statements and management's discussion and analysis). Accordingly, the Company intends to rely on this blanket relief for the filing of the Company's audited consolidated financial statements for the year ended December 31, 2019 (and related management's discussion and analysis thereon) (collectively, the " FY 2019 Disclosure Documents ") as a result of delays caused by the COVID-19 pandemic. The Company and its auditor, under this temporary relief, are making every effort to issue and file the FY 2019 Disclosure Documents at the earliest opportunity and currently expects to file them no later than June 14, 2020.

The Company confirms that all material business developments are available on SEDAR at www.sedar.com. Until such time as the FY 2019 Disclosure Documents are filed, the Company's management and other insiders will observe a trading blackout consistent with the principles contained in section 9 of National Policy 11-207 – Failure to File Cease Orders and Revocations in Multiple Jurisdictions.

Issuance of Shares

The Company also announces that it has issued 29,762 common shares of the Company to Waterside Capital Advisors Inc. ("Waterside") and 200,341 common shares of the Company to Israel Morgenshtern ("Morgenshtern") as consideration for services rendered by Waterside and Morgenshtern to the Company pursuant to the terms of previously announced consulting agreements. The securities were issued to Waterside and Morgenshtern at deemed prices of $0.42 and $0.4405 per common share, respectively, and are subject to a hold period expiring August 28, 2020. The issuance is subject to final Exchange acceptance of the related filings.

BUSINESS OF A2Z

ABOUT A2Z Technologies Canada Corp.

A2Z Technologies Canada Corp. is an innovative technology company based out of Israel, specializing in military technology and expanding into the civilian markets. A2Z has been operating for over 30 years and has a client base with 75 recurring clients, including the Israel Defense Forces, Security Forces, and Ministry of Defence among others. A2Z plans to leverage their cash flow-generating core-business to expand into the civilian robotics and automobile markets.

According to Zion Market Research, the Military Robotics space is expected to reach $53.93B by 2027 for a projected CAGR of 13.5%.(Summary of Report)

Highlights:

Core Business: A2Z's line of products include unmanned remote-controlled vehicles of various sizes designed for intricate bomb disposal, counter terrorism, and firefighting, as well as energy storage power packs/generators. A2Z also provides maintenance services to both external and in-house complex electronic systems and products to over 75 clients.

A2Z has been an Israel Ministry of Defense contractor for over 30 years and a significant portion of its business is long-term service contracts.

Expansion into Civilian Markets: To drive growth, A2Z plans to adapt its military technologies for the much larger civilian markets. One patent-pending product is a capsule (FTICS) that prevents vehicle fires resulting from collisions. A2Z has also been granted a patent for a smart vehicle cover device that protects automobiles from the elements while the vehicle is parked and is stowed away safely in the vehicle's bumper when not in use.

Fuel Tank Intelligent Containment System (FTICS): In the event of a collision, the FTICS system installed into the fuel tank prevents the ignition of fuel, thereby mitigating the spread of fire and explosion, minimizing risk to human life and property damage. According to the NFPA, from 2014 to 2016, an estimated 171,500 highway vehicle fires occurred in the United States, resulting in an annual average of 345 deaths, 1,300 injuries, and $1.1 billion in property loss annually. Click Here for an explanatory video of the FTICS.

Management: CEO Bentsur Joseph's previous venture, Comfy Interactive, was acquired by Shamrock Holdings, the family investment firm founded by Roy Disney. Previously, Bentsur Joseph was the chairman of Elad Hotels whose holdings include the Plaza Hotel in New York City.

Bentsur Joseph has a ~64% ownership stake in the business with 30,000,000 shares subject to an escrow agreement.

For more information regarding A2Z, please visit the Company's website at www.a2zas.com.

Twitter: @A2Z_Advanced

On Behalf of the Board,

Bentsur Joseph, CEO

Investor Relations Contact

Arlen Hansen, KIN Communications
Toll Free: 1-866-684-6730
az@kincommunications.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to inherent risks and uncertainties. All statements within this news release, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those described in forward-looking statements. Factors that could cause actual results to differ materially from those described in forward-looking statements include fluctuations in market prices, including metal prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under applicable laws.

SOURCE: A2Z Technologies Canada Corp.

ReleaseID: 587590

The medical X-ray detectors market is likely to experience obstacles in its positive growth trajectory during and post the COVID-19 crisis.

DUBAI, UAE / ACCESSWIRE / April 29, 2020 / The global medical X-ray detectors market is poised to exhibit an impressive CAGR during the forecast period (2020-2029), according to a recent market study of Future Market Insights (FMI). Factors predominantly fueling the growth of market include increasing focus on radiological diagnostic tests, a growing number of chronic diseases among people, and the introduction of efficient X-ray devices.

Furthermore, the rising incidence of injuries, trauma, and cancers is significantly driving the number of diagnostic imaging tests annually, in turns increasing demand for x-ray detectors. The introduction of new technology such as the Veradius X-ray system, is propelling the demand for thin flat detector devices and computed radiography (CR) detectors among hospitals and diagnostic centers.

"The market will be adversely affected by the global coronavirus pandemic. The swiftly spreading infection has resulted in travel restrictions and the workforce shortages, thereby hindering the production and supply of X-ray detectors. Hospitals are prioritizing patients of COVID-19, and have put all non-essential procedures on hold for the time being," states the report.

To know more about this market, request a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10909

Segmental Highlights

Direct flat panel X-ray detectors are expected to account for 45% of revenue generation on the back of its ability to perform all current radiological modalities at a reduced dose, in addition to providing high-quality radiograph which can be used for real-time imaging.

Large-area flat-panel detectors are gaining higher traction than small-area variants, with 7 in 10 units of medical X-ray detectors sold in 2019 being large-area flat-panel.

Digital X-ray equipment is exhibiting substantial growth as compared to its counterpart, retrofit X-ray systems. The digital X-ray equipment is projected to capture more than 2/3rd of total market value by the end of the forecast period.

Hospitals are expected to remain the most lucrative end-use segment owing to higher usage. Diagnostic centers will contribute to sales in the foreseeable future due to growing demand.

North America will persist dominance and is expected to account for more than 1/3rd of global revenue, invigorated by healthcare spending and the availability of innovative products.

Asia to Register significant growth, owing to increasing government spending on medical technology for better treatments.

For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-10909

Report Coverage:

Products covered: Direct flat-panel, Indirect flat-panel, and Computed Radiography (CR) Detectors

Modality covered: Fixed detectors and Portable Detector

End-uses covered: Hospitals and Diagnostic Center

Regions: North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/medical-x-ray-detectors-market
Press Release Source: https://www.futuremarketinsights.com/press-release/medical-x-ray-detectors-marke

SOURCE: Future Market Insights

ReleaseID: 587582

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased resTORbio, Inc. ("resTORbio" or the "Company") (NASDAQ:TORC) stock prior to April 29, 2020.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of resTORbio with Adicet Bio, Inc. ("Adicet"). Under the terms of the merger, Adicet would merge with a wholly-owned subsidiary of resTORbio in an all-stock transaction, and the equityholders of Adicet would become the majority owners (75%) of resTORbio's outstanding common stock upon the close of the merger. To learn more about the action and your rights, go to:

resTORbio, Inc. Loss Form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The resTORbio merger investigation concerns whether the Board of resTORbio breached their fiduciary duties to stockholders by agreeing to enter into this transaction and whether the merger undervalues resTORbio relative to Adicet, thereby harming resTORbio shareholders.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky LLP

ReleaseID: 587589

The FMI study offers a thorough analysis of the impact of global coronavirus outbreak on the performance of sea bream market in 2020 and ahead.

DUBAI, UAE / ACCESSWIRE / April 29, 2020 / The global sea bream market is forecast to exhibit an impressive CAGR of 6% during the forecast period (2020-2029), according to a market study by Future Market Insights (FMI). However, the market will experience both positive and negative impacts of the global pandemic of COVID-19, says a new Future Market Insights (FMI) study.

With the widespread outbreak of COVID-19, the demand for packaged and frozen products has spiked as people are inclined towards non-perishable foods that can be stored. The demand for fresh seafood has thus sharply declined and prices have fallen. Meanwhile, suppliers and processors are struggling to keep the workflow running as the supply chain is being disrupted on the back of travel restrictions, operations with a limited workforce, and a number of other logistical difficulties.

"On the other hand, the demand for sea bream from the snacks industry, which falls in the non-perishables category, is likely to mitigate for the significant damages," states the FMI report.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6257

Key Takeaways

Conventional sea bream remains the most consumed type, and accounts for 75% of overall market value, on the back of lower sales prices.
Organic sea breams segment is witnessing demand among consumers and is expected to grow in value owing to its benefits such as the demand growth for organic sea breams is growing at a healthy pace owing to its benefits such as low-fat content, low liver lipid content, and high hepatosomatic index.
Fresh sea breams are projected to exhibit growth during the forecast period, backed by to multiple benefits fresh sea breams offer to consumers.
Foodservice provider segment persists contributing to more than 1/3rd of sales in the global sea bream market, invigorated by high usage of sea breams in snacks and daily food.
Food processing, animal feed, and pet food industries, in addition to retail and household sectors, will contribute to growth in the sales of sea breams.
Europe holds nearly 1/3rd of market value due to high awareness regarding the health benefits associated with sea breams such as red breams, and black breams.
European market is majorly invigorated by expanding the practice of veganism and escalating per capita fish consumption in countries such as Norway and Spain.
North America is projected to surpass the market value of Europe by the end of the forecast period due to the surging consumption of seafood in snacks.
Oceania is also registering significant growth on the back of owing to the rising consumer demand for premium food products, such as organic sea bream and sea bass.

Request the Coronavirus Impact Analysis across Industries and Markets https://www.futuremarketinsights.com/covid19/rep-gb-6257

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Report Coverage:

Sources: Animal and Plant

Applications: Food & beverages, dietary supplements and others.

Regions: North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/sea-bream-market
Press Release Source: https://www.futuremarketinsights.com/press-release/sea-bream-market

SOURCE: Future Market Insights

ReleaseID: 587569